Skip to main content
logo
InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.9204
+0.0174 (1.93%)
At close: Apr 2, 2026, 4:00 PM EDT
0.9124
-0.0080 (-0.87%)
After-hours: Apr 2, 2026, 7:45 PM EDT

InflaRx Revenue

In the year 2025, InflaRx had annual revenue of 29.33K EUR, down -82.31%. InflaRx had revenue of -33.93K in the quarter ending December 31, 2025.

Revenue (ttm)
29.33K EUR
Revenue Growth
-82.31%
P/S Ratio
1,915.33
Revenue / Employee
396 EUR
Employees
74
Market Cap
65.96M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202529.33K-136.46K-82.31%
Dec 31, 2024165.79K102.70K162.79%
Dec 31, 202363.09K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pelthos Therapeutics16.80M
Alterity Therapeutics4.43M
BeyondSpring1.88M
MediciNova409.66K
iBio, Inc.300.00K
Impact BioMedical32.00K
Revenue Rankings

IFRX News

More News